Tobias Reichmuth and Marc P. Bernegger are two serial entrepreneurs and startup investors who together have built Maximon, an incubator for impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions. Tobias holds a PhD in Business Administration from EBS Universität für Wirtschaft und Recht, and Marc holds a master’s degree in Law from UZH.
Tobias’ interest in the longevity topic was first sparked back in 2016, when he was studying at the Singularity University, in California, and heard the process of aging referred to as a sickness — which, given the right tools and science, could be combatted. In 2021 he started Maximon together with his friend, Marc.
Maximon builds companies along the longevity value-chain, from enablers such as science-based supplements, genetic improvements, and personalized treatments, to necessities such as life-long learning, healthspan-insurances for centennials, to sustainable asset management solutions replacing today’s pensions and co-living for active and healthy seniors. Marc and Tobias also host a longevity conference, called Longevity Investors, which addresses the investor community and brings together science and capital.
Maximon holds substantial shares in all of their ventures. This way there is no need for hidden fees, and the incentives of both Maximon and the founders are aligned: their common goal is to increase the value of company shares as much as possible. Founders also receive funding up to Series A, as well as hands-on operational support from Marc and Tobias.
Marc and Tobias have invested CHF 10M of their own money into the Maximon fund, and they don’t pay themselves salaries. It’s the long term upside that interests them.
